Efficacy and safety of pyronaridine–artesunate versus artemether–lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial

BACKGROUND: In Nigeria, declining responsiveness to artemether–lumefantrine (AL), the artemisinin-based combination therapy (ACT) of choice since 2005, has been reported. Pyronaridine–artesunate (PA) is a newer fixed-dose ACT recently prequalified by the WHO for the treatment of uncomplicated falcip...

Descripción completa

Detalles Bibliográficos
Autores principales: Falade, Catherine O., Orimadegun, Adebola E., Olusola, Fiyinfoluwa I., Michael, Obaro S., Anjorin, Oluwafunmibi E., Funwei, Roland I., Adedapo, Aduragbenro D., Olusanya, Abiola L., Orimadegun, Bose E., Mokuolu, Olugbenga A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182553/
https://www.ncbi.nlm.nih.gov/pubmed/37179349
http://dx.doi.org/10.1186/s12936-023-04574-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182553/
https://www.ncbi.nlm.nih.gov/pubmed/37179349
http://dx.doi.org/10.1186/s12936-023-04574-7

Ejemplares similares